Project cooperationUpdated on 25 May 2026

Innovative AI-driven digital tools for Cancer Missions calls

Senior Researcher at Idener

Seville, Spain

About

Idener was started in 2010 by a group of recent PhD graduates with a strong theoretical background in control and systems engineering. Soon, they got fascinated with the early advancements in machine learning, which they incorporated into their research – the seed of the company was already planted. Nowadays, we are a team of engineers, scientists, and software developers exploring AI's potential for solving challenging science and engineering problems. To do so, we use an extended interpretation of AI that fuses machine learning, systems modelling, advanced control, and mathematical optimization. We aim to create new, better, sustainable technologies and business models that ultimately contribute to human development. Our focus is to exploit the potential of AI beyond the software industry, where it still has massive untapped opportunities to create vast amounts of value. Learning from the challenges of our partners, we are developing applications as diverse as green chemical process optimization, improved design of materials, microbial platforms enhancement, child abuse prosecution and environmental regeneration – and yet, we have just scraped the surface of a whole new world of possibilities. It is hard to think of any industry that AI is unlikely to touch in a significant way now or in the near future. So far, we have already developed successful projects across industries, including energy, manufacturing, logistics, chemical processing, biotech, agrifood, and cybersecurity. There, our approach to AI provides real impact as competitive advantage, increased revenues, cost-savings, reduced time-to-market, and business process efficiency.

Stage

  • Completing the consortia

Topic

  • HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
  • HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
  • HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
  • HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
  • HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)
  • HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine
  • HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients

Type

  • Consortium/Coordinator seeks Partners
  • Offering Expertise to Consortias

Similar opportunities